Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

High Ambient Solar UV Correlates with Greater Beta HPV Seropositivity in New South Wales, Australia.

Kricker A, Weber MF, Brenner N, Banks E, Pawlita M, Sitas F, Hodgkinson VS, Rahman B, van Kemenade CH, Armstrong BK, Waterboer T.

Cancer Epidemiol Biomarkers Prev. 2019 Oct 9. doi: 10.1158/1055-9965.EPI-19-0400. [Epub ahead of print]

PMID:
31597664
2.

Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer.

Butt J, Jenab M, Pawlita M, Overvad K, Tjonneland A, Olsen A, Boutron-Ruault MC, Carbonnel F, Mancini FR, Kaaks R, Kühn T, Boeing H, Trichopoulou A, Karakatsani A, Palli D, Pala VM, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, van Gils CH, Vermeulen RCH, Weiderpass E, Quirós JR, Duell EJ, Sánchez MJ, Dorronsoro M, Huerta JM, Ardanaz E, Van Guelpen B, Harlid S, Perez-Cornago A, Gunter MJ, Murphy N, Freisling H, Aune D, Waterboer T, Hughes DJ.

Cancer Epidemiol Biomarkers Prev. 2019 Sep;28(9):1552-1555. doi: 10.1158/1055-9965.EPI-19-0313.

PMID:
31481495
3.

Antibody responses to cancer antigens identify patients with a poor prognosis among HPV-positive and HPV-negative head and neck squamous cell carcinoma patients.

Laban S, Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende CC, Dyckhoff G, Boscolo-Rizzo P, Ezić J, Marienfeld R, Möller P, Kraus JM, Völkel G, Kestler HA, Brunner C, Schuler PJ, Wigand MC, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Waterboer T, Butt J.

Clin Cancer Res. 2019 Aug 23. pii: clincanres.1490.2019. doi: 10.1158/1078-0432.CCR-19-1490. [Epub ahead of print]

PMID:
31444248
4.

Multilaboratory Assessment of Epstein-Barr Virus Serologic Assays: the Case for Standardization.

Liu Z, Yu KJ, Coghill AE, Brenner N, Cao SM, Chen CJ, Chen Y, Doolan DL, Hsu WL, Labo N, Middeldorp JM, Miley W, Simon J, Wang CP, Waterboer T, Whitby D, Xie SH, Ye W, Hildesheim A.

J Clin Microbiol. 2019 Oct 23;57(11). pii: e01107-19. doi: 10.1128/JCM.01107-19. Print 2019 Nov.

PMID:
31434722
5.

Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.

D'Souza G, Clemens G, Troy T, Castillo RG, Struijk L, Waterboer T, Bender N, Pierorazio PM, Best SR, Strickler H, Wiley DJ, Haddad RI, Posner M, Fakhry C.

Cancer Prev Res (Phila). 2019 Oct;12(10):689-700. doi: 10.1158/1940-6207.CAPR-19-0185. Epub 2019 Aug 16.

PMID:
31420362
6.

Squamous cell carcinoma of the nasal cavity: A descriptive analysis of cases from the head and neck 5000 study.

Dale OT, Pring M, Davies A, Leary S, Ingarfield K, Toms S, Waterboer T, Pawlita M, Ness AR, Thomas SJ.

Clin Otolaryngol. 2019 Aug 16. doi: 10.1111/coa.13414. [Epub ahead of print]

PMID:
31419373
7.

Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.

Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende C, Dyckhoff G, Boscolo-Rizzo P, Ezic J, Marienfeld RB, Möller P, Völkel G, Kraus JM, Kestler HA, Brunner C, Schuler PJ, Wigand M, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Butt J, Waterboer T, Laban S.

Int J Cancer. 2019 Dec 15;145(12):3436-3444. doi: 10.1002/ijc.32623. Epub 2019 Aug 26.

PMID:
31407331
8.

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.

Tengvall K, Huang J, Hellström C, Kammer P, Biström M, Ayoglu B, Lima Bomfim I, Stridh P, Butt J, Brenner N, Michel A, Lundberg K, Padyukov L, Lundberg IE, Svenungsson E, Ernberg I, Olafsson S, Dilthey AT, Hillert J, Alfredsson L, Sundström P, Nilsson P, Waterboer T, Olsson T, Kockum I.

Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16955-16960. doi: 10.1073/pnas.1902623116. Epub 2019 Aug 2.

PMID:
31375628
9.

Antibody responses to flagellin C and Streptococcus gallolyticus pilus proteins in colorectal cancer.

Butt J, Fernández de Larrea N, Tjalsma H, Roelofs R, Kato I, Martín V, Pérez-Gómez B, Moreno V, Dierssen-Sotos T, Castilla J, Fernández-Tardón G, Amiano P, Salas D, Alguacil J, Jiménez-Moleón JJ, Huerta JM, de Sanjosé S, Del Campo R, Kogevinas M, Pollán M, Pawlita M, Waterboer T, Boleij A, Aragonés N.

Sci Rep. 2019 Jul 26;9(1):10847. doi: 10.1038/s41598-019-47347-6.

10.

Smoking, Helicobacter Pylori Serology, and Gastric Cancer Risk in Prospective Studies from China, Japan, and Korea.

Butt J, Varga MG, Wang T, Tsugane S, Shimazu T, Zheng W, Abnet CC, Yoo KY, Park SK, Kim J, Jee SH, Qiao YL, Shu XO, Waterboer T, Pawlita M, Epplein M.

Cancer Prev Res (Phila). 2019 Oct;12(10):667-674. doi: 10.1158/1940-6207.CAPR-19-0238. Epub 2019 Jul 26.

PMID:
31350279
11.

HPV Status Improves Classification of Head and Neck Gray Zone Cancers.

Ren J, Xu W, Su J, Ren X, Bender N, Habbous S, de Almeida JR, Goldstein DP, Cheng D, Chen Z, Mirshams M, Rahini M, Huang SH, Spreafico A, Hansen A, Kim J, Waldron J, Perez-Ordonez B, Zhao Y, Hung R, Waterboer T, Liu G.

J Dent Res. 2019 Jul;98(8):879-887. doi: 10.1177/0022034519853771.

PMID:
31282843
12.

Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable.

Ren J, Xu W, Su J, Ren X, Cheng D, Chen Z, Bender N, Mirshams M, Habbous S, de Almeida JR, Perez-Ordonez B, Goldstein DP, Wang JR, Bratman SV, Huang SH, Jang R, Zhao Y, Waterboer T, Hung RJ, Liu G.

Int J Cancer. 2019 Jul 3. doi: 10.1002/ijc.32548. [Epub ahead of print]

PMID:
31269236
13.

Natural history, dynamics, and ecology of human papillomaviruses in genital infections of young women: protocol of the PAPCLEAR cohort study.

Murall CL, Rahmoun M, Selinger C, Baldellou M, Bernat C, Bonneau M, Boué V, Buisson M, Christophe G, D'Auria G, Taroni F, Foulongne V, Froissart R, Graf C, Grasset S, Groc S, Hirtz C, Jaussent A, Lajoie J, Lorcy F, Picot E, Picot MC, Ravel J, Reynes J, Rousset T, Seddiki A, Teirlinck M, Tribout V, Tuaillon É, Waterboer T, Jacobs N, Bravo IG, Segondy M, Boulle N, Alizon S.

BMJ Open. 2019 Jun 11;9(6):e025129. doi: 10.1136/bmjopen-2018-025129.

14.

Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.

Kreimer AR, Ferreiro-Iglesias A, Nygard M, Bender N, Schroeder L, Hildesheim A, Robbins HA, Pawlita M, Langseth H, Schlecht NF, Tinker LF, Agalliu I, Smoller SW, Ness-Jensen E, Hveem K, D'Souza G, Visvanathan K, May B, Ursin G, Weiderpass E, Giles GG, Milne RL, Cai Q, Blot WJ, Zheng W, Weinstein SJ, Albanes D, Brenner N, Hoffman-Bolton J, Kaaks R, Barricarte A, Tjønneland A, Sacerdote C, Trichopoulou A, Vermeulen RCH, Huang WY, Freedman ND, Brennan P, Waterboer T, Johansson M.

Ann Oncol. 2019 Jun 11. pii: mdz138. doi: 10.1093/annonc/mdz138. [Epub ahead of print]

15.

Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America.

Dominguez RL, Cherry CB, Estevez-Ordonez D, Mera R, Escamilla V, Pawlita M, Waterboer T, Wilson KT, Peek RM, Tavera G, Williams SM, Gulley ML, Emch M, Morgan DR.

BMC Cancer. 2019 Jun 7;19(1):545. doi: 10.1186/s12885-019-5726-x.

16.

Soy and tea intake on cervical cancer risk: the Singapore Chinese Health Study.

Paul P, Koh WP, Jin A, Michel A, Waterboer T, Pawlita M, Wang R, Yuan JM, Butler LM.

Cancer Causes Control. 2019 Aug;30(8):847-857. doi: 10.1007/s10552-019-01173-3. Epub 2019 Jun 1.

PMID:
31154549
17.

Epstein Barr virus antibody reactivity and gastric cancer: A population-based case-control study.

Aragonés N, Fernández de Larrea N, Pastor-Barriuso R, Michel A, Romero B, Pawlita M, Mayorgas-Torralba S, Martín V, Moreno V, Casabonne D, Castilla J, Fernandez-Tardón G, Dierssen-Sotos T, Capelo R, Salas D, Salcedo-Bellido I, Chirlaque MD, Brenner N, Pedraza M, Bessa X, Pérez-Gómez B, Butt J, Kogevinas M, Del Campo R, de Sanjosé S, Waterboer T, Pollán M.

Cancer Epidemiol. 2019 Aug;61:79-88. doi: 10.1016/j.canep.2019.05.008. Epub 2019 May 30.

PMID:
31154081
18.

First-void urine as a non-invasive liquid biopsy source to detect vaccine-induced human papillomavirus antibodies originating from cervicovaginal secretions.

Van Keer S, Willhauck-Fleckenstein M, Pattyn J, Butt J, Tjalma WAA, Van Ostade X, Hens N, Van Damme P, Waterboer T, Vorsters A.

J Clin Virol. 2019 Aug;117:11-18. doi: 10.1016/j.jcv.2019.05.004. Epub 2019 May 11.

19.

Risk factors for herpes simplex virus type-1 infection and reactivation: Cross-sectional studies among EPIC-Norfolk participants.

Forbes H, Warne B, Doelken L, Brenner N, Waterboer T, Luben R, Wareham NJ, Warren-Gash C, Gkrania-Klotsas E.

PLoS One. 2019 May 9;14(5):e0215553. doi: 10.1371/journal.pone.0215553. eCollection 2019.

20.

Helicobacter pylori Seropositivity: Prevalence, Associations, and the Impact on Incident Metabolic Diseases/Risk Factors in the Population-Based KORA Study.

Wawro N, Amann U, Butt J, Meisinger C, Akmatov MK, Pessler F, Peters A, Rathmann W, Kääb S, Waterboer T, Linseisen J.

Front Public Health. 2019 Apr 24;7:96. doi: 10.3389/fpubh.2019.00096. eCollection 2019.

21.

Comparison of multiplex-serology and ELISA based methods in detecting HPV16 L1 antibody responses in paired saliva and serum samples of healthy men.

Loimaranta V, Sievi K, Werner J, Pawlita M, Waterboer T, Butt J, Syrjänen S.

J Virol Methods. 2019 Aug;270:26-33. doi: 10.1016/j.jviromet.2019.04.007. Epub 2019 Apr 17.

PMID:
31004663
22.

Post-treatment human papillomavirus antibody kinetics in cervical cancer patients.

Piontek T, Harmel C, Pawlita M, Carow K, Schröter J, Runnebaum IB, Dürst M, Graw F, Waterboer T.

Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20180295. doi: 10.1098/rstb.2018.0295.

PMID:
30955486
23.

Concordance of Self- and Clinician-Collected Anal Swabs to Detect Human Papillomavirus in a Sample of HIV-Negative Men.

Yared NF, Horvath KJ, Baker JV, Thyagarajan B, Waterboer T, Kulasingam S.

J Low Genit Tract Dis. 2019 Jul;23(3):200-204. doi: 10.1097/LGT.0000000000000475.

PMID:
30946259
24.

Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany - Results from a nationwide population-based survey.

Loenenbach AD, Poethko-Müller C, Pawlita M, Thamm M, Harder T, Waterboer T, Schröter J, Deleré Y, Wichmann O, Wiese-Posselt M.

Int J Infect Dis. 2019 Jun;83:3-11. doi: 10.1016/j.ijid.2019.03.022. Epub 2019 Mar 20.

25.

Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses' Health Studies.

Fortner RT, Terry KL, Bender N, Brenner N, Hufnagel K, Butt J, Waterboer T, Tworoger SS.

Br J Cancer. 2019 Apr;120(8):855-860. doi: 10.1038/s41416-019-0422-9. Epub 2019 Mar 21.

PMID:
30894687
26.

Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort study.

Basu P, Muwonge R, Bhatla N, Nene BM, Joshi S, Esmy PO, Poli URR, Joshi G, Verma Y, Zomawia E, Shastri SS, Pimple S, Anantharaman D, Prabhu PR, Hingmire S, Sauvaget C, Lucas E, Pawlita M, Gheit T, Jayant K, Malvi SG, Siddiqi M, Michel A, Butt J, Sankaran S, Rameshwari Ammal Kannan TP, Varghese R, Divate U, Willhauck-Fleckenstein M, Waterboer T, Müller M, Sehr P, Vashist S, Mishra G, Jadhav R, Thorat R, Tommasino M, Pillai MR, Sankaranarayanan R; Indian HPV vaccine study group.

Papillomavirus Res. 2019 Jun;7:75-81. doi: 10.1016/j.pvr.2019.01.004. Epub 2019 Jan 31.

27.

Validation of monoplex assays detecting antibodies against Corynebacterium diphtheriae and Clostridium tetani toxins, rubella virus and parvovirus B19 for incorporation into Multiplex Serology.

Brenner N, Butt J, Bomfim IL, Tabatabai J, Pawlita M, Schnitzler P, Waterboer T.

Methods. 2019 Apr 1;158:44-53. doi: 10.1016/j.ymeth.2019.01.013. Epub 2019 Jan 28.

PMID:
30703462
28.

Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000.

Lang S, Schimansky S, Beynon R, Penfold C, Davies A, Waylen A, Thomas S, Pring M, Pawlita M, Waterboer T, Ness AR.

Head Neck. 2019 Jul;41(7):2074-2084. doi: 10.1002/hed.25660. Epub 2019 Jan 30.

PMID:
30698303
29.

Development and validation of HIV-1 Multiplex Serology.

Kranz LM, Gärtner B, Michel A, Pawlita M, Waterboer T, Brenner N.

J Immunol Methods. 2019 Mar;466:47-51. doi: 10.1016/j.jim.2019.01.007. Epub 2019 Jan 18.

PMID:
30660622
30.

Sex differences in HPV immunity among adults without cancer.

Windon MJ, Waterboer T, Hillel AT, Chien W, Best S, Stewart C, Akst L, Troy T, Bender N, Miles B, Ryan WR, Mandal R, Pitman K, Eisele DW, Fakhry C, D'Souza G.

Hum Vaccin Immunother. 2019;15(7-8):1935-1941. doi: 10.1080/21645515.2019.1568157. Epub 2019 Mar 19.

PMID:
30650013
31.

Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii.

Brenner N, Mentzer AJ, Butt J, Braband KL, Michel A, Jeffery K, Klenerman P, Gärtner B, Schnitzler P, Hill A, Taylor G, Demontis MA, Guy E, Hadfield SJ, Almond R, Allen N, Pawlita M, Waterboer T.

PLoS One. 2019 Jan 7;14(1):e0210407. doi: 10.1371/journal.pone.0210407. eCollection 2019.

32.

Bacterial Translocation and Risk of Liver Cancer in a Finnish Cohort.

Yang B, Petrick JL, Thistle JE, Pinto LA, Kemp TJ, Tran HQ, Gewirtz AT, Waterboer T, Fedirko V, Jenab M, Graubard BI, Weinstein SJ, Albanes D, McGlynn KA.

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):807-813. doi: 10.1158/1055-9965.EPI-18-0240. Epub 2019 Jan 2.

PMID:
30602499
33.

Validation of Multiplex Serology detecting human herpesviruses 1-5.

Brenner N, Mentzer AJ, Butt J, Michel A, Prager K, Brozy J, Weißbrich B, Aiello AE, Meier HCS, Breuer J, Almond R, Allen N, Pawlita M, Waterboer T.

PLoS One. 2018 Dec 27;13(12):e0209379. doi: 10.1371/journal.pone.0209379. eCollection 2018.

34.

Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.

Schimansky S, Lang S, Beynon R, Penfold C, Davies A, Waylen A, Thomas S, Pring M, Pawlita M, Waterboer T, Ness A.

Head Neck. 2019 Apr;41(4):1053-1062. doi: 10.1002/hed.25543. Epub 2018 Dec 14.

PMID:
30549147
35.

Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma.

Halec G, Waterboer T, Brenner N, Butt J, Hardy WD, DʼSouza G, Wolinsky S, Macatangay BJ, Pawlita M, Detels R, Martínez-Maza O, Hussain SK.

J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):e53-e63. doi: 10.1097/QAI.0000000000001916.

PMID:
30531297
36.

Differences in Chlamydia trachomatis seroprevalence between ethnic groups cannot be fully explained by socioeconomic status, sexual healthcare seeking behavior or sexual risk behavior: a cross-sectional analysis in the HEalthy LIfe in an Urban Setting (HELIUS) study.

Hulstein SH, Matser A, Alberts CJ, Snijder MB, Willhauck-Fleckenstein M, Hufnagel K, Prins M, de Vries HJC, Schim van der Loeff MF, Waterboer T.

BMC Infect Dis. 2018 Dec 3;18(1):612. doi: 10.1186/s12879-018-3533-7.

37.

Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors.

Lorenzo I, Fernández-de-Larrea N, Michel A, Romero B, Lope V, Bessa X, Moreno V, Martín V, Amiano P, Castilla J, Tardón A, Dierssen-Sotos T, Peiró R, Díaz-Santos M, Navarro C, Jiménez-Moleón JJ, Butt J, Barricarte A, Ruiz I, Molina-de-la-Torre AJ, Casabonne D, Pérez-Gómez B, Kogevinas M, Del Campo R, de Sanjosé S, Pollán M, Waterboer T, Aragonés N.

Eur J Cancer Prev. 2019 Jul;28(4):294-303. doi: 10.1097/CEJ.0000000000000483.

PMID:
30489354
38.

Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.

Butt J, Varga MG, Blot WJ, Teras L, Visvanathan K, Le Marchand L, Haiman C, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GYF, Tinker LE, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Hyslop T, Um C, Grodstein F, Song M, Zeleniuch-Jacquotte A, Berndt S, Hildesheim A, Waterboer T, Pawlita M, Epplein M.

Gastroenterology. 2019 Jan;156(1):175-186.e2. doi: 10.1053/j.gastro.2018.09.054. Epub 2018 Oct 6.

PMID:
30296434
39.

DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival.

Ambatipudi S, Langdon R, Richmond RC, Suderman M, Koestler DC, Kelsey KT, Kazmi N, Penfold C, Ho KM, McArdle W, Ring SM, Pring M, Waterboer T, Pawlita M, Gaunt TR, Davey Smith G, Thomas S, Ness AR, Relton CL.

Oral Oncol. 2018 Oct;85:87-94. doi: 10.1016/j.oraloncology.2018.08.021. Epub 2018 Sep 5.

40.

Virological and Serological Predictors of Anal High-grade Squamous Intraepithelial Lesions Among Human Immunodeficiency Virus-positive Men Who Have Sex With Men.

Marra E, Siegenbeek van Heukelom ML, Leeman A, Waterboer T, Meijer CJLM, Snijders PJF, King AJ, Cairo I, van Eeden A, Brokking W, van der Weele P, Quint W, Prins JM, de Vries HJC, Schim van der Loeff MF.

Clin Infect Dis. 2019 Apr 8;68(8):1377-1387. doi: 10.1093/cid/ciy719.

PMID:
30165551
41.

Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer.

Epplein M, Butt J, Zhang Y, Hendrix LH, Abnet CC, Murphy G, Zheng W, Shu XO, Tsugane S, Qiao YL, Taylor PR, Shimazu T, Yoo KY, Park SK, Kim J, Jee SH, Waterboer T, Pawlita M, You WC, Pan KF.

Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1472-1479. doi: 10.1158/1055-9965.EPI-18-0582. Epub 2018 Aug 29.

PMID:
30158280
42.

Cytomegalovirus (CMV) seroprevalence in the adult population of Germany.

Lachmann R, Loenenbach A, Waterboer T, Brenner N, Pawlita M, Michel A, Thamm M, Poethko-Müller C, Wichmann O, Wiese-Posselt M.

PLoS One. 2018 Jul 25;13(7):e0200267. doi: 10.1371/journal.pone.0200267. eCollection 2018.

43.

Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium.

Butt J, Blot WJ, Teras LR, Visvanathan K, Le Marchand L, Haiman CA, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GY, Tinker LF, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Waterboer T, Pawlita M, Epplein M.

Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1186-1194. doi: 10.1158/1055-9965.EPI-18-0249. Epub 2018 Jul 23.

44.

Advancing the public health applications of Chlamydia trachomatis serology.

Woodhall SC, Gorwitz RJ, Migchelsen SJ, Gottlieb SL, Horner PJ, Geisler WM, Winstanley C, Hufnagel K, Waterboer T, Martin DL, Huston WM, Gaydos CA, Deal C, Unemo M, Dunbar JK, Bernstein K.

Lancet Infect Dis. 2018 Dec;18(12):e399-e407. doi: 10.1016/S1473-3099(18)30159-2. Epub 2018 Jul 5. Review.

PMID:
29983342
45.

Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.

Varga MG, Cai H, Waterboer T, Murphy G, Shimazu T, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH, Cho ER, Kim J, Abnet CC, Tsugane S, Cai Q, Zheng W, Pawlita M, Shu XO, Epplein M.

Dig Dis Sci. 2018 Oct;63(10):2765-2772. doi: 10.1007/s10620-018-5154-9. Epub 2018 Jun 8.

46.

Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study.

Jansen F, Verdonck-de Leeuw IM, Cuijpers P, Leemans CR, Waterboer T, Pawlita M, Penfold C, Thomas SJ, Waylen A, Ness AR.

Psychooncology. 2018 Sep;27(9):2245-2256. doi: 10.1002/pon.4816. Epub 2018 Jul 23.

47.

Biomarkers for early identification of recurrences in HPV-driven oropharyngeal cancer.

Mirghani H, Lang Kuhs KA, Waterboer T.

Oral Oncol. 2018 Jul;82:108-114. doi: 10.1016/j.oraloncology.2018.05.015. Epub 2018 May 21. Review.

PMID:
29909884
48.

Predictors of oropharyngeal cancer survival in Europe.

Anantharaman D, Billot A, Waterboer T, Gheit T, Abedi-Ardekani B, Lagiou P, Lagiou A, Ahrens W, Holcátová I, Merletti F, Kjaerheim K, Polesel J, Simonato L, Alemany L, Mena Cervigon M, Macfarlane TV, Znaor A, Thomson PJ, Robinson M, Canova C, Conway DI, Wright S, Healy CM, Toner ME, Pawlita M, Tommasino M, Brennan P.

Oral Oncol. 2018 Jun;81:89-94. doi: 10.1016/j.oraloncology.2018.04.016. Epub 2018 May 2.

49.

Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial.

Michels J, Becker N, Suciu S, Kaiser I, Benner A, Kosaloglu-Yalcin Z, Agoussi S, Halama N, Pawlita M, Waterboer T, Eichmüller SB, Jäger D, Eggermont AMM, Zörnig I.

Oncoimmunology. 2018 Feb 12;7(6):e1428157. doi: 10.1080/2162402X.2018.1428157. eCollection 2018.

50.

Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations.

Trabert B, Waterboer T, Idahl A, Brenner N, Brinton LA, Butt J, Coburn SB, Hartge P, Hufnagel K, Inturrisi F, Lissowska J, Mentzer A, Peplonska B, Sherman ME, Wills GS, Woodhall SC, Pawlita M, Wentzensen N.

J Natl Cancer Inst. 2019 Feb 1;111(2):129-136. doi: 10.1093/jnci/djy084.

Supplemental Content

Loading ...
Support Center